A24 Valued at $3.5B with Thrive Capital’s New Investmentby Mark Eisenberg 26.06.2024A24 secures new investment from Thrive Capital, led by Josh Kushner, boosting its value to $3.5B and aiming for major ...
Howard Hughes Holdings: Exec Buys Stock Amid Housing Boomby Mark Eisenberg 26.06.2024"Howard Hughes Holdings Exec Elena Verbinskaya shows confidence in company by purchasing $22,390 in stock amid key developments and financial ...
Investment Firms Increase Stakes in Marvell Technology, Inc.by Lilu Anderson 23.06.2024Wedmont Private Capital ups stake in Marvell Technology amid broader institutional interest; MRVL stock at $71.89, analysts set target at ...
Indie Semiconductor COO Sells $10K+ in Stock, Receives RSUsby Mark Eisenberg 22.06.2024"Indie Semiconductor COO sells $10k+ in stock amid equity moves and company updates, spotlighting investor interest and market performance."
AbbVie Sets $1.55 Quarterly Dividend, Piper Sandler Ups Targetby Mark Eisenberg 22.06.2024AbbVie sets quarterly dividend at $1.55 per share, showcasing financial health and strategic growth. Recent acquisitions bolster positive outlook.
Converge Tech Solutions: Shareholders Approve Key Resolutionsby Lilu Anderson 20.06.2024"Converge Technology Solutions announces shareholder voting results from its June 19, 2024 AGM, including director elections and key resolutions."
Pakistan Regulator’s Edict Spurs $9bn Supply Chain Finance Marketby Mark Eisenberg 19.06.2024"Pakistan's regulator boosts the $9bn supply chain finance market with new initiatives, enhancing transparency and efficiency in trade."
Fisher Investments: $3B Strategic Partnership with Advent, ADIAby Mark Eisenberg 16.06.2024Advent and ADIA invest $2.5-$3B, valuing Fisher Investments at $12.75B. Founder Ken Fisher sells holdings. New board member: Advent's Mussafer.
Avidity Biosciences CFO Sells $3.7M in Stock Amid Positive Newsby Terry Bingman 15.06.2024Avidity Biosciences sees share ownership shift as MacLean reduces holding under Rule 10b5-1 Plan; positive sector developments bolster outlook.
Avidity Biosciences Director Sells $3.8M in Stockby Mark Eisenberg 15.06.2024Arthur A. Levin sells 40K Avidity shares; BofA ups target to $45 as FDA advances myotonic dystrophy treatment. AI-assisted article ...